We demonstrate a promising approach to identify robust molecular markers for targeted treatment of acute myeloid leukemia. We show that our method outperforms several state-of-the-art approaches in id
Genetic mutations associated with acute myeloid leukemia (AML) can also be detected in age-related clonal hematopoiesis, making confident assignment of detected variants to malignancy challenging part
